|
|
|
|
|
|
|
|
open access
Conclusions
This is the first comprehensive study of the BRCA1/2 mutation spectrum in Bulgaria and will assist the establishment of efficient protocols
for genetic testing and individualized risk assessment for Bulgarian breast/ovarian
cancer patients and healthy individuals at a high-risk.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.